Abstract

A library of queuine analogues targeting the modification of tRNA isoacceptors for Asp, Asn, His and Tyr catalysed by queuine tRNA ribosyltransferase (QTRT, also known as TGT) was evaluated in the treatment of a chronic multiple sclerosis model--murine experimental autoimmune encephalomyelitis. Several active 7-deazaguanines emerged, together with a structure activity relationship involving the necessity for a flexible alkyl chain of fixed length.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call